Fujian Medical University Cancer Hospital
Welcome,         Profile    Billing    Logout  
 0 Trials 
3 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Liu, Shuoyan
NCT04848753: Perioperative Toripalimab (JS001) Combined With Neoadjuvant Chemotherapy in Patients With Resectable Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma

Active, not recruiting
3
663
RoW
Toripalimab combined with cisplatin and paclitaxel, Placebo combined with cisplatin and paclitaxel
Shanghai Junshi Bioscience Co., Ltd.
Resectable Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma
05/27
05/27
REVO, NCT05007145: PD-1 Inhibitor Combined With Neoadjuvant Chemotherapy in Subjects With Resectable Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma

Recruiting
2
92
RoW
PD-1 inhibitor, Albumin-Bound Paclitaxel, Cisplatin, Radiation
Fujian Cancer Hospital, Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Esophageal Neoplasms, Esophageal Squamous Cell Carcinoma
08/23
08/23
GENTLEMAN, NCT06510543: Goal-directed Enteral Nutritional Perioperative Management

Recruiting
N/A
400
RoW
Goal-directed EN therapy, Conventional EN therapy
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Esophagus Cancer
08/26
05/31
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Liu, Shuoyan
NCT04848753: Perioperative Toripalimab (JS001) Combined With Neoadjuvant Chemotherapy in Patients With Resectable Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma

Active, not recruiting
3
663
RoW
Toripalimab combined with cisplatin and paclitaxel, Placebo combined with cisplatin and paclitaxel
Shanghai Junshi Bioscience Co., Ltd.
Resectable Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma
05/27
05/27
REVO, NCT05007145: PD-1 Inhibitor Combined With Neoadjuvant Chemotherapy in Subjects With Resectable Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma

Recruiting
2
92
RoW
PD-1 inhibitor, Albumin-Bound Paclitaxel, Cisplatin, Radiation
Fujian Cancer Hospital, Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Esophageal Neoplasms, Esophageal Squamous Cell Carcinoma
08/23
08/23
GENTLEMAN, NCT06510543: Goal-directed Enteral Nutritional Perioperative Management

Recruiting
N/A
400
RoW
Goal-directed EN therapy, Conventional EN therapy
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Esophagus Cancer
08/26
05/31

Download Options